Navigate today’s most pressing health industry challenges with a leading global expert by your side.
Discover intelligent digital solutions to help improve outcomes, manage costs, and solve the toughest healthcare challenges.
Meet growing needs for innovative insurance solutions while increasing operational health and improving compliance.
Property & casualty advisory services
Modern flood insurance program
Investment, advisory & trading services
Financial modeling & industrialization
Insurance risk assessment
Geographic rating insights
Premium comparison platform
Retirement & Benefits
Deliver on the promises of the past and create smart solutions for the future.
Pension administration & communication
Retirement benefits administration platform
Compensations & benefits
Benefit plan evaluation
Health & welfare benefits administration platform
Manage complex risks using data-driven insights, advanced approaches, and deep industry experience.
Risk technology plays a major role
Auto policy underwriting
Software performance enhancement
Mortgage platform for investments & reinsurance
Solvency II reporting & compliance
This is a place where your ideas and insights make an impact. Where an independent, entrepreneurial spirit is an advantage. And where diversity of thought and experience makes us who we are.
Data-driven insight. Deep expertise. Transformative innovation. Since 1947, Milliman has delivered intelligent solutions to improve health and financial security.
Andrew Jackson is a consultant with the San Diego office of Milliman. He joined the firm in 2020 and has been working in the pharmaceutical and healthcare industry since 2006.
Andrew has previously worked as a consultant for UnitedHealth Group’s (UHG) OptumInsight Commercial Consulting division. He has supported pharmaceutical, payer, and provider clients in a wide variety of engagements including market access, competitive landscaping, drug pricing, and Medicare value-based arrangements. Prior to joining UHG, Andrew spent time at Merck and other biopharmaceutical firms as a drug development chemist.
Andrew’s experience includes: